Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:conditionStudied |
gptkb:cancer
|
| gptkbp:endDate |
1998
|
| gptkbp:focus |
postmenopausal women with node-positive, hormone receptor-positive breast cancer
|
| gptkbp:fullName |
Southwest Oncology Group S8814 trial
|
| https://www.w3.org/2000/01/rdf-schema#label |
S8814 (breast cancer trial)
|
| gptkbp:intervention |
gptkb:tamoxifen
chemotherapy aromatase inhibitor |
| gptkbp:location |
gptkb:United_States
|
| gptkbp:notableFinds |
benefit of chemotherapy followed by tamoxifen in hormone receptor-positive breast cancer
|
| gptkbp:publishedResults |
2003
|
| gptkbp:result |
overall survival
disease-free survival |
| gptkbp:sponsor |
gptkb:Southwest_Oncology_Group
|
| gptkbp:startYear |
1989
|
| gptkbp:bfsParent |
gptkb:SWOG_Cancer_Research_Network
|
| gptkbp:bfsLayer |
7
|